Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104797 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zsófia Aradi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, 22 Móricz Zsigmond Street, H-4032 Debre…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Rheumatoid Factor, Immunoglobulin A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of the paper was to characterize rheumatoid factor IgA, IgG, and IgM isotypes in patients with Sjögren’s syndrome (SS) subsets, based on the absence or presence of joint complaints of different etiologies. In total, 164 SS patients were grouped based on whether they had polyarthritis as an extraglandular manifestation (n = 73, SS+pa), rheumatoid arthritis as an associated autoimmune disorder (n = 46, SS+RA), or Sjögren’s syndrome without inflammatory joint pain (n = 45, SS). The highest IgA rheumatoid factor isotype levels were detected in SS patients, whereas the lowest levels were found in the SS+RA group, without a significant difference. Neither IgG nor IgM RF differed significantly between the patient subclasses. In addition to other disease-specific markers, seropositive patients who were seropositive for any RF isotype were significantly more frequently anti-Ro/SS-A and anti-La/SS-B positive and had higher ESSDAI levels. In SS and SS+pa patients, a strong negative correlation was observed between IgA RF and age, whereas a strong positive correlation was found between IgA RF and ESSDAI, RF, IgA, IgG, anti-Ro/SS-A, and anti-La/SS-B levels. High total IgG levels together with high IgA RF levels occurred most frequently in SS patients (p = 0.05), whereas the combination of normal IgG and high IgM RF was significantly more frequent in the SS+RA group. The co-occurrence of high total IgG and normal IgM RF did not differ significantly between the patient subsets; however, this was the combination with the highest sensitivity (94.5%) for SS+pa patients. Based on our findings, rheumatoid factor isotypes have an additive value in the differentiation of non-erosive polyarthritis and erosive rheumatoid arthritis during the disease course of patients with Sjögren’s syndrome. All rheumatoid factor isotypes predict a more severe disease course, but IgA RF may serve as a candidate for being an early, poor prognostic factor for SS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, 22 Móricz Zsigmond Street, H-4032 Debrecen, Hungary.
- Gyula Petrányi Clinical Immunology and Allergology Doctoral School, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
- Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Kassai út 26, H-4028 Debrecen, Hungary.
- Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, H-4032 Debrecen, Hungary.
ORCID-Profile: Gábor Nagy, Antónia Szántó
Zitieren
APA
Aradi, Z., Bói, B., Nagy, G., Antal-Szalmás, P., Mezei, K., Horváth, I. F., & Szántó, A. (2025). Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104797
Vancouver
Aradi Z, Bói B, Nagy G, Antal-Szalmás P, Mezei K, Horváth IF, et al. Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104797
BibTeX
@article{Aradi2025,
author = {Aradi, Zsófia and Bói, Bernadett and Nagy, Gábor and Antal-Szalmás, Péter and Mezei, Kincső and Horváth, Ildikó Fanny and Szántó, Antónia},
title = {Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104797}
}
EUVIMED